Keros Therapeutics (KROS) Accumulated Expenses (2019 - 2026)
Keros Therapeutics (KROS) posted Accumulated Expenses of $7.74 million for Q2 2026, down 61.2% from $19.96 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics' Accumulated Expenses came in at $16.04 million, down 23.1% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 28.3% (FY2020 to FY2025).
- In prior years, Keros Therapeutics' Accumulated Expenses was $20.87 million in FY2024 (+16.5%), $17.92 million in FY2023 (+40.5%), $12.75 million in FY2022 (+73.8%) and $7.34 million in FY2021 (+59.1%).
- The Q2 2026 figure stands as the lowest quarterly Accumulated Expenses since Q2 2022.
- On a year-over-year basis, Accumulated Expenses increased in four of the last seven quarters, with growth averaging 9.3%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2024, with growth of 81.4%; the weakest was Q2 2026, with a decline of 61.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Keros Therapeutics | 224.56 Mn | -1.70 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.74 Mn |
| Dec 31, 2025 | 16.04 Mn |
| Sep 30, 2025 | 15.17 Mn |
| Jun 30, 2025 | 19.96 Mn |
| Mar 31, 2025 | 17.29 Mn |
| Dec 31, 2024 | 20.87 Mn |
| Sep 30, 2024 | 22.17 Mn |
| Jun 30, 2024 | 13.61 Mn |
| Mar 31, 2024 | 12.68 Mn |
| Dec 31, 2023 | 17.92 Mn |
| Sep 30, 2023 | 12.22 Mn |
| Jun 30, 2023 | 11.95 Mn |
| Mar 31, 2023 | 10.78 Mn |
| Dec 31, 2022 | 12.75 Mn |
| Sep 30, 2022 | 8.42 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 7.70 Mn |
| Dec 31, 2021 | 7.34 Mn |
| Sep 30, 2021 | 7.36 Mn |
| Jun 30, 2021 | 5.71 Mn |
API Access
Keros Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();